Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSIST-CT: Intra-arterial cocktail therapy after thrombectomy for ischemic stroke
NCT04202549Completed
- Start
- Dec 2019
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of argatroban, dexamethasone and edaravone in ischemic stroke. Primary endpoint: Proportion of favorable outcome at 90 days. Started Dec 2019; status: completed.
02
Drugs
argatrobandexamethasoneedaravone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04202549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04202549.